At concentrations of 10 μg/mL and 50 μg/mL, MMP-9 expression was significantly elevated, suggesting that high-dose FN promotes inflammation and matrix degradation, which may exacerbate atherosclerosis and increase the risk of plaque instability in advanced stages. The gene discussed is FN1; the disease is atherosclerosis.